【MGRC 0155 交流专区】基因组学资源

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2017	30 Jun 2016	30 Jun 2017	30 Jun 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	2,912	1,851	9,872	10,432
2	Profit/(loss) before tax	390	119	668	1,744
3	Profit/(loss) for the period	335	114	589	1,737
4	Profit/(loss) attributable to ordinary equity holders of the parent	335	114	589	1,737
5	Basic earnings/(loss) per share (Subunit)	0.32	0.12	0.57	1.85
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2348		0.2060

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2017	30 Sep 2016	30 Sep 2017	30 Sep 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,384	3,287	6,384	3,287
2	Profit/(loss) before tax	-790	835	-790	835
3	Profit/(loss) for the period	-823	829	-823	829
4	Profit/(loss) attributable to ordinary equity holders of the parent	-823	829	-823	829
5	Basic earnings/(loss) per share (Subunit)	-0.80	0.88	-0.80	0.88
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2268		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2017

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2017	31 Dec 2016	31 Dec 2017	31 Dec 2016
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,908	2,046	13,292	5,333
2	Profit/(loss) before tax	-694	-463	-1,484	372
3	Profit/(loss) for the period	-808	-471	-1,631	358
4	Profit/(loss) attributable to ordinary equity holders of the parent	-808	-471	-1,631	358
5	Basic earnings/(loss) per share (Subunit)	-0.78	-0.46	-1.58	0.35
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2190		0.2348

icy97

Date of change	26 Feb 2018
Name	DATO DR NORRAESAH BINTI HAJI MOHAMAD
Age	70
Gender	Female
Nationality	Malaysia
Designation	Director
Directorate	Executive
Type of change	Resignation
Reason	Other business commitments

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2018	31 Mar 2017	31 Mar 2018	31 Mar 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,559	1,627	19,851	6,960
2	Profit/(loss) before tax	-1,354	-94	-2,838	278
3	Profit/(loss) for the period	-1,457	-104	-3,088	254
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,457	-104	-3,088	254
5	Basic earnings/(loss) per share (Subunit)	-1.41	-0.10	-2.98	0.25
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.2049		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2018	30 Jun 2017	30 Jun 2018	30 Jun 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,307	2,912	26,158	9,872
2	Profit/(loss) before tax	-1,539	390	-4,377	668
3	Profit/(loss) for the period	-1,455	335	-4,533	589
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,455	335	-4,533	589
5	Basic earnings/(loss) per share (Subunit)	-1.40	0.32	-4.38	0.57
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1910		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2018	30 Sep 2017	30 Sep 2018	30 Sep 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,170	6,384	7,170	6,384
2	Profit/(loss) before tax	-376	-790	-376	-790
3	Profit/(loss) for the period	-546	-823	-546	-823
4	Profit/(loss) attributable to ordinary equity holders of the parent	-546	-823	-546	-823
5	Basic earnings/(loss) per share (Subunit)	-0.53	-0.80	-0.53	-0.80
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1857		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2018

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2018	31 Dec 2017	31 Dec 2018	31 Dec 2017
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,929	6,908	14,099	13,292
2	Profit/(loss) before tax	-911	-694	-1,287	-1,484
3	Profit/(loss) for the period	-991	-808	-1,537	-1,631
4	Profit/(loss) attributable to ordinary equity holders of the parent	-991	-808	-1,537	-1,631
5	Basic earnings/(loss) per share (Subunit)	-0.96	-0.78	-1.48	-1.58
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1761		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Mar 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Mar 2019	31 Mar 2018	31 Mar 2019	31 Mar 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	6,610	6,559	20,709	19,851
2	Profit/(loss) before tax	-929	-1,354	-2,216	-2,838
3	Profit/(loss) for the period	-958	-1,457	-2,495	-3,088
4	Profit/(loss) attributable to ordinary equity holders of the parent	-958	-1,457	-2,495	-3,088
5	Basic earnings/(loss) per share (Subunit)	-0.93	-1.41	-2.41	-2.98
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1669		0.2348

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2019	30 Jun 2018	30 Jun 2019	30 Jun 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,017	6,307	27,726	26,158
2	Profit/(loss) before tax	-1,300	-1,539	-3,516	-4,377
3	Profit/(loss) for the period	-1,343	-1,445	-3,838	-4,533
4	Profit/(loss) attributable to ordinary equity holders of the parent	-1,343	-1,445	-3,838	-4,533
5	Basic earnings/(loss) per share (Subunit)	-1.30	-1.40	-3.71	-4.38
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1539		0.1910

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR "COMPANY")PROPOSED DISPOSAL OF 100% EQUITY INTEREST HELD IN MPATH SDN BHD, A WHOLLYOWNED SUBSIDIARY OF MGRC ("PROPOSED DISPOSAL")
On behalf of the Board of Directors of MGRC (“Board”), AmInvestment Bank Berhad wishes to announce that MGRC and Gribbles Pathology (Malaysia) Sdn. Bhd. (“GPMSB”) had on 11 October 2019, entered into a conditional sale and purchase agreement (“SPA”) to dispose of MGRC’s entire equity interest in MPath Group (as defined herein) (“Sale Shares”) for a total cash consideration of RM42.0 million (“Disposal Consideration”), subject to the terms of the SPA. The Proposed Disposal entails the disposal of the following subsidiaries of MGRC:- (a)    100% equity interest in MPath Sdn Bhd (“MPath”); and (b)    the following wholly-owned subsidiaries of MPath:- (i)      100% equity interest in Clinipath (Malaysia) Sdn Bhd (“CMSB”); (ii)      100% equity interest in Clinipath Capital Sdn Bhd (“CCSB”); and (iii)     100% equity interest in Medical Scan Sdn Bhd (“MSSB”) (Collectively, referred to as the “MPath Group”) The Proposed Disposal is deemed a major disposal pursuant to Rule 10.11A of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad (“Bursa Securities”) (“Listing Requirements”). Upon completion of the Proposed Disposal, the Board proposes to declare a distribution via a cash dividend of RM0.22 per ordinary share in MGRC (“MGRC Share”) held on an entitlement date to be determined (“Proposed Distribution”).

http://www.bursamalaysia.com/market/listed-companies/company-announcements/6309045

Attachments MGRC - Proposed Disposal.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Sep 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Sep 2019	30 Sep 2018	30 Sep 2019	30 Sep 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	7,848	7,170	7,848	7,170
2	Profit/(loss) before tax	95	-376	95	-376
3	Profit/(loss) for the period	-33	-546	-33	-546
4	Profit/(loss) attributable to ordinary equity holders of the parent	-33	-546	-33	-546
5	Basic earnings/(loss) per share (Subunit)	-0.03	-0.53	-0.03	-0.53
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1518		0.1539

icy97

Type	Announcement
Subject	OTHERS
Description	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR "THE COMPANY") - DISPOSAL OF ENTIRE ISSUED SHARE CAPITAL OF MGRC INTERNATIONAL SDN. BHD., A WHOLLY-OWNED SUBSIDIARY
The Board of Directors of MGRC wishes to announce that the Company had on today disposed of its entire issued share capital of MGRC International Sdn. Bhd., a wholly-owned subsidiary of the Company to Puan Elinor binti Kamalul Azmi and Encik Mohd Zailani bin Mahmood for a total cash consideration of RM2.00. MGRC International Sdn. Bhd., a private limited company which was incorporated in Malaysia on 25 April 2012 is principally involved in providing genome sequencing, bioinformatics analysis services, genetic screening services, providing online access to genomic data and bioinformatics applications. The Company has not commenced operations since its incorporation on 25 April 2012. As at the date of this announcement, the total issued share capital is RM2.00 comprising of 2 ordinary shares. The disposal of MGRC International Sdn. Bhd. will enable MGRC to focus on its core business. Following the disposal, MGRC International Sdn. Bhd. ceased to be a subsidiary of MGRC. The disposal of MGRC International Sdn. Bhd. is not expected to have a material effect on the earnings or net assets per share of MGRC for the financial year ending 30 June 2020. None of the Directors or major shareholders of MGRC or persons connected with them has any interest, direct or indirect, in the said disposal. This announcement is dated 19 November 2019.

icy97

icy97 发表于 2-11-2019 07:24 AM
http://www.bursamalaysia.com/market/listed-companies/company-announcements/6309045

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) NON RELATED PARTY TRANSACTIONS
Description	PROPOSED DISPOSAL OF 100% EQUITY INTEREST HELD IN MPATH SDN BHD TO GRIBBLES PATHOLOGY (MALAYSIA) SDN BHD FOR A TOTAL CASH CONSIDERATION OF RM42.0 MILLION (PROPOSED DISPOSAL)
This announcement is dated 24 December 2019. Reference is made to the announcements by AmInvestment Bank Berhad (“AmInvestment Bank”) on behalf of MGRC in relation to the Proposed Disposal dated 11 October 2019 and 21 November 2019 (“Earlier Announcements”) and the circular to the shareholders of MGRC in relation to the Proposed Disposal dated 27 November 2019 (“Circular”). Unless otherwise stated, the abbreviations and definitions used throughout this announcement shall have the same meaning as those previously defined in the Earlier Announcements and Circular. On behalf of MGRC, AmInvestment Bank wishes to announce that the last of the Condition Precedent under the the SPA was fulfilled and the SPA has become unconditional. Both MGRC and the Buyer have agreed that the Completion has taken place on 24 December 2019.  The first tranche of RM37.8 million was received by MGRC today. Accordingly, MPath Group ceased to be a subsidiary of the MGRC Group.   Please refer to MGRC’s announcement on even date for further details on MGRC’s status pursuant to Rule 8.03A and 8.03 of the Listing Requirements.

icy97

Type	Announcement
Subject	PARAGRAPH/RULE 8.03A COMPANIES FIRST ANNOUNCEMENT
Description	MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD ("MGRC" OR "THE COMPANY")- First Announcement Pursuant to Rule 8.03A of the ACE Market Listing Requirements of Bursa Malaysia Securities Berhad ("Bursa Securities") ("Listing Requirements")
Reference is made to the Company’s announcement on 24 December 2019 pertaining to the completion of the disposal of the 100% equity interest held in MPath Sdn. Bhd. to Gribbles Pathology (Malaysia) Sdn. Bhd. (“Disposal”) of which the first tranche amounting to RM37.8 million was received today. The Board of Directors of MGRC wishes to announce that, following the completion of the Disposal, MGRC has triggered Rule 8.03A(2) of the Listing Requirements. Accordingly, MGRC is now classified as an affected listed corporation. Please be informed that the Company had on 5 December 2019 submitted its application to Bursa Securities to seek concurrence that MGRC may not be classified as a Cash Company pursuant to Rule 8.03 and Guidance Note 2 of the Listing Requirements. The Company is pending the concurrence from Bursa Securities on this matter. Please refer to the attachment for details of the Company's obligations as an affected listed corporation. This announcement is dated 24 December 2019.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3011831

Attachments MGRC - First Announcement on Rule 8.03A.pdf

icy97

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Entitlement subject	Special Dividend
Entitlement description	Special cash dividend of RM0.22 per ordinary share
Ex-Date	09 Jan 2020
Entitlement date	10 Jan 2020
Entitlement time	5:00 PM
Financial Year End	30 Jun 2019
Period
Share transfer book & register of members will be	to  closed from (both dates inclusive) for the purpose of determining the entitlement
Payment Date	21 Jan 2020
a.Securities transferred into the Depositor's Securities Account before 4:30 pm in respect of transfers	10 Jan 2020
b.Securities deposited into the Depositor's Securities Account before 12:30 pm in respect of securities exempted from mandatory deposit
c. Securities bought on the Exchange on a cum entitlement basis according to the Rules of the Exchange.
Number of new shares/securities issued (units) (If applicable)
Entitlement indicator	Currency
Announced Currency	Malaysian Ringgit (MYR)
Disbursed Currency	Malaysian Ringgit (MYR)
Entitlement in Currency	Malaysian Ringgit (MYR) 0.2200

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 31 Dec 2019

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		31 Dec 2019	31 Dec 2018	31 Dec 2019	31 Dec 2018
		$$'000	$$'000	$$'000	$$'000

1	Revenue	4,960	103	5,139	253
2	Profit/(loss) before tax	24,708	-1,101	24,199	-2,079
3	Profit/(loss) for the period	24,232	-991	24,199	-1,537
4	Profit/(loss) attributable to ordinary equity holders of the parent	24,232	-991	24,199	-1,537
5	Basic earnings/(loss) per share (Subunit)	23.41	-0.96	23.38	-1.48
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.3603		0.1539

icy97

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Particulars of substantial Securities Holder

Name	NEURAMATIX SDN. BHD.
Address	No. 27-9, Level 9 Signature Office, Bandar Mid Valley, Kuala Lumpur 59200 Wilayah Persekutuan Malaysia.
Company No.	200201002330 (569993-A)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	28 Feb 2020	4,181,400	Disposed	Direct Interest
	Name of registered holder	Neuramatix Sdn. Bhd.
	Address of registered holder	No. 27-9, Level 9 Signature Office, Bandar Mid Valley, 59200 Kuala Lumpur, Wilayah Persekutuan
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of shares in open market.
Nature of interest	Direct Interest
Direct (units)	50
Direct (%)	0
Indirect/deemed interest (units)	58,354,070
Indirect/deemed interest (%)	56.375
Total no of securities after change	58,354,120
Date of notice	03 Mar 2020
Date notice received by Listed Issuer	03 Mar 2020

icy97

Notice of Interest Sub. S-hldr (Section 137 of CA 2016)

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Particulars of Substantial Securities Holder

Name	CREST ADVISORY BERHAD
Address	100.3.041 129 Offices, Block J, Jaya One, 72A, Jalan Universiti, Section 13, Petaling Jaya 46200 Selangor Malaysia.
Company No.	201901013684 (1323012-X)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares
Name & address of registered holder	Crest Advisory Berhad100.3.041 129 Offices, Block J,Jaya One, 72A, Jalan Universiti, Section 13,46200 Petaling Jaya, Selangor

Date interest acquired & no of securities acquired
Date interest acquired	05 Mar 2020
No of securities	29,000,000
Circumstances by reason of which Securities Holder has interest	Acquisition of shares
Nature of interest	Direct Interest
Total no of securities after change
Direct (units)	29,000,000
Direct (%)	28.016
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Date of notice	06 Mar 2020
Date notice received by Listed Issuer	09 Mar 2020

icy97

MALAYSIAN GENOMICS RESOURCE CENTRE BERHAD

Particulars of substantial Securities Holder

Name	SYNAMATIX SDN. BHD.
Address	No. 27-9, Level 9 Signature Office, Bandar Mid Valley, Kuala Lumpur 59200 Wilayah Persekutuan Malaysia.
Company No.	200101002725 (538481-U)
Nationality/Country of incorporation	Malaysia
Descriptions (Class)	Ordinary Shares

Details of changes

No	Date of change	No of securities	Type of Transaction	Nature of Interest
1	05 Mar 2020	29,000,000	Disposed	Direct Interest
	Name of registered holder	Synamatix Sdn. Bhd.
	Address of registered holder	No. 27-9, Level 9 Signature Office, Bandar Mid Valley, 59200 Kuala Lumpur, Wilayah Persekutuan
	Description of "Others" Type of Transaction

Circumstances by reason of which change has occurred	Disposal of shares in open market.
Nature of interest	Direct Interest
Direct (units)	29,354,070
Direct (%)	28.359
Indirect/deemed interest (units)	0
Indirect/deemed interest (%)	0
Total no of securities after change	29,354,070
Date of notice	09 Mar 2020
Date notice received by Listed Issuer	09 Mar 2020